Vascular Medicine

Episodes 1-7 of 7

• 

  RestartResume

  The Path Forward: What’s On The Horizon?

  MinuteCE®

  The Path Forward: What’s On The Horizon?

  • 

    

    Manesh R. Patel, MD

    Peer

  1.50 program credits

• 

  MinuteCE®

  New Frontiers in Anticoagulation: Factor XI/XIa Inhibitors

  • 

    

    Christopher B. Granger, MD

    Peer

  • 

    

    Manesh R. Patel, MD

    Peer

  • 

    

    M. Cecilia Bahit, MD

    Peer

  • 

    

    Elaine Hylek, MD, MPH

    Peer

  1.50 credits 5 episodes

• 

  RestartResume

  While DOACs are Good for Some Things, They Are Not for Everyone

  MinuteCE®

  While DOACs are Good for Some Things, They Are Not for Everyone

  • 

    

    M. Cecilia Bahit, MD

    Peer

  1.50 program credits

• 

  RestartResume

  Questions & Answers from the AHA 2023 Symposium

  MinuteCE®

  Questions & Answers from the AHA 2023 Symposium

  • 

    

    Manesh R. Patel, MD

    Peer

  • 

    

    M. Cecilia Bahit, MD

    Peer

  • 

    

    Elaine Hylek, MD, MPH

    Peer

  1.50 program credits

• 

  RestartResume

   The DOAC Revolution: What Have We Learned?

  MinuteCE®

   The DOAC Revolution: What Have We Learned?

  • 

    

    Christopher B. Granger, MD

    Peer

  1.50 program credits

• 

  RestartResume

  While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?

  MinuteCE®

  While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?

  • 

    

    Elaine Hylek, MD, MPH

    Peer

  1.50 program credits

• 

  RestartResume

  Experts Discuss Longevity and Durability with TAVR

  CME/CE

  Experts Discuss Longevity and Durability with TAVR

  • 

    

    Suzanne J. Baron, MD

    Peer

  • 

    

    Jonathan A. Bradlow, MD, FACC

    Peer

  • 

    

    Kendra J. Grubb, MD

    Peer